Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00697918Phase 3Completed
A Phase 3 trial of carisbamate in focal onset seizure, sponsored by SK Life Science, Inc.. Started Mar 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00697918.